6 days Ago By ABMN Staff
XTX Topco Ltd purchased a new position in shares of Senseonics Holdings, Inc. ( NYSE:SENS – Free Report ) during the fourth quarter, Holdings Channel reports. The firm purchased 341,914 shares of the company’s stock, valued at approximately $179,000.
A number of other hedge funds also recently bought and sold shares of SENS. Geode Capital Management LLC boosted its position in Senseonics by 3.2% during the third quarter.
Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after purchasing an additional 179,103 shares in the last quarter. Ridgecrest Wealth Partners LLC purchased a new position in Senseonics during the fourth quarter worth approximately $60,000. Charles Schwab Investment Management Inc.
boosted its position in Senseonics by 9.0% during the fourth quarter. Charles Schwab Investment Management Inc.
now owns 3,339,698 shares of the company’s stock worth $1,748,000 after purchasing an additional 274,842 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Senseonics during the fourth quarter worth approximately $26,000.
Finally, HighTower Advisors LLC purchased a new position in shares of Senseonics in the fourth quarter valued at approximately $32,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.
Senseonics Price Performance Senseonics stock opened at $0.72 on Tuesday. Senseonics Holdings, Inc.
has a 52-week low of $0.25 and a 52-week high of $1.40.
The firm has a market capitalization of $472.08 million, a price-to-earnings ratio of -5.55 and a beta of 0.
84. The company has a fifty day simple moving average of $0.68 and a 200-day simple moving average of $0.
61. The company has a quick ratio of 2.38, a current ratio of 2.
47 and a debt-to-equity ratio of 59.17. Wall Street Analysts Forecast Growth Several research firms recently commented on SENS.
HC Wainwright reissued a “buy” rating and issued a $2.00 price objective on shares of Senseonics in a research note on Wednesday, March 5th. Mizuho began coverage on shares of Senseonics in a report on Thursday, April 10th.
They set an “outperform” rating and a $2.00 target price for the company. View Our Latest Analysis on SENS Senseonics Company Profile ( Free Report ) Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. Further Reading Want to see what other hedge funds are holding SENS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Senseonics Holdings, Inc.
( NYSE:SENS – Free Report ). Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter .
.
